LYTIR

Insider · SEC Form 4 · Chief Commercial Officer

Hopman Mark

In the 12 months to Nov 19, 2026, on the open market: sold $1.5M of BBNX. Filed a median of 2 business days after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $1.5M in total.Jun: Insider sales $19KSep: Insider sales $1.4MOct: Insider sales $37KNov: Insider sales $19KDecJanFebMarAprMayJunJulAugSepOctNov$1.4M
Insider purchases above the line: $0Insider sales below: $1.5M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. BBNXSold: Beta Bionics, Inc. Nov 16, 2026 775 shares filed Nov 18, 2026 54,143 shares held directly after, as filed 10b5-1 plan filing $13K
  2. BBNXSold: Beta Bionics, Inc. Nov 2, 2026 370 shares filed Nov 4, 2026 54,143 shares held directly after, as filed 10b5-1 plan filing $6K
  3. BBNXSold: Beta Bionics, Inc. Oct 26, 2026 821 shares filed Oct 28, 2026 54,513 shares held directly after, as filed 10b5-1 plan filing $16K
  4. BBNXSold: Beta Bionics, Inc. Oct 14, 2026 775 shares filed Oct 16, 2026 55,334 shares held directly after, as filed 10b5-1 plan filing $13K
  5. BBNXSold: Beta Bionics, Inc. Oct 1, 2026 370 shares filed Oct 5, 2026 56,109 shares held directly after, as filed 10b5-1 plan filing $7K
  6. BBNXSold: Beta Bionics, Inc. Sep 16, 2026 30,779 shares filed Sep 17, 2026 56,479 shares held directly after, as filed 10b5-1 plan filing $620K
  7. BBNXSold: Beta Bionics, Inc. Sep 14, 2026 775 shares filed Sep 15, 2026 86,382 shares held directly after, as filed 10b5-1 plan filing $12K
  8. BBNXSold: Beta Bionics, Inc. Sep 9, 2026 35,994 shares filed Sep 18, 2026 88,033 shares held directly after, as filed 10b5-1 plan filing $665K
  9. BBNXSold: Beta Bionics, Inc. Sep 2, 2026 5,327 shares filed Sep 3, 2026 124,027 shares held directly after, as filed filing $102K
  10. BBNXSold: Beta Bionics, Inc. Jun 24, 2026 1,258 shares filed Jun 25, 2026 129,354 shares held directly after, as filed 10b5-1 plan filing $19K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Planned sales (Form 144)

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Notices filed under this filer's SEC CIK in the same 12 months, newest first; the figure is the market value the notice states. Not every notice becomes a sale. Every recent notice

  1. BBNXMARK HOPMAN filed Nov 16, 2026 Beta Bionics, Inc. Officer 451 shares planned sale date 11/16/2026 filing $7K
  2. BBNXMARK HOPMAN filed Oct 1, 2026 Beta Bionics, Inc. Officer 2,660 shares planned sale date 10/01/2026 filing $50K
  3. BBNXMARK HOPMAN filed Sep 16, 2026 Beta Bionics, Inc. Officer 28,119 shares planned sale date 09/16/2026 filing $541K
  4. BBNXMARK HOPMAN filed Sep 9, 2026 Beta Bionics, Inc. Officer 40,305 shares planned sale date 09/09/2026 filing $779K

Other Form 4 entries

Not counted above: entries this filer reported on Form 4 in the same 12 months that are not open-market purchases or sales. Each entry is one line of a filing.

  • BBNX: option exercise or conversion (code M), 1 entry, Nov 16, 2026
Code M
An exercise or conversion of a derivative security received from the company, such as stock options.

Source: the same SEC Form 4 filings. The codes are the SEC's own transaction codes; the meanings above are a plain-words reading of the SEC's Form 4 instructions.